Prospera Financial Services Inc Gilead Sciences, Inc. Transaction History

Prospera Financial Services Inc

$3.82 Billion
Q3 2024

A detailed history of Prospera Financial Services Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Prospera Financial Services Inc holds 78,615 shares of GILD stock, worth $7.22 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

78,615

Previous 61,937 26.93%

Holding current value

$7.22 Million

Previous $4.25 Million 55.07%

% of portfolio

0.17%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$66.59 - $83.99 $1.11 Million - $1.4 Million	16,678 Added 26.93%	78,615 $6.59 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $883,531 - $1.02 Million	13,991 Added 29.18%	61,937 $4.25 Million
Q1 2024 Aug 13, 2024	SELL	$71.58 - $87.29 $613,870 - $748,599	-8,576 Reduced 13.85%	53,361 $3.91 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $261,500 - $296,548	3,569 Added 8.04%	47,946 $3.88 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $96,787 - $105,597	1,309 Added 3.04%	44,377 $3.33 Million
Q2 2023 Aug 08, 2023	BUY	$76.01 - $86.7 $282,985 - $322,784	3,723 Added 9.46%	43,068 $3.32 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $241,593 - $275,250	3,125 Added 8.63%	39,345 $3.26 Million
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $411,249 - $590,412	-6,599 Reduced 15.41%	36,220 $3.11 Million
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $32,687 - $37,337	549 Added 1.3%	42,819 $2.64 Million
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $130,908 - $147,442	2,268 Added 5.67%	42,270 $2.61 Million
Q1 2022 May 04, 2022	BUY	$57.92 - $72.58 $862,834 - $1.08 Million	14,897 Added 59.34%	40,002 $2.38 Million
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $422,498 - $479,543	-6,512 Reduced 20.6%	25,105 $1.82 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $728,547 - $786,021	10,763 Added 51.61%	31,617 $2.21 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $20,500 - $22,400	-323 Reduced 1.53%	20,854 $1.44 Million
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $127,080 - $144,998	2,118 Added 11.11%	21,177 $1.37 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $1.04 Million - $1.18 Million	18,327 Added 2503.69%	19,059 $1.11 Million
Q3 2020 Nov 04, 2020	SELL	$62.1 - $78.08 $972,237 - $1.22 Million	-15,656 Reduced 95.53%	732 $46,000
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $3.51 Million - $4.07 Million	-48,504 Reduced 74.75%	16,388 $1.26 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $3.11 Million - $3.98 Million	49,667 Added 326.22%	64,892 $4.85 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $160,828 - $176,905	2,610 Added 20.69%	15,225 $989,000
Q3 2019 Oct 22, 2019	SELL	$62.51 - $69.0 $28,567 - $31,533	-457 Reduced 3.5%	12,615 $800,000
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $144,899 - $162,487	-2,342 Reduced 27.38%	6,211 $409,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $424,490 - $476,016	6,861 Added 110.47%	13,072 $892,000
Q1 2019 May 02, 2019	BUY	$62.53 - $70.05 $146,445 - $164,057	2,342 Added 37.71%	8,553 $574,000
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $137,062 - $178,856	2,264 Added 57.36%	6,211 $409,000
Q3 2018 Oct 25, 2018	SELL	$71.28 - $78.92 $56,239 - $62,267	-789 Reduced 16.66%	3,947 $300,000
Q2 2018 Jul 18, 2018	SELL	$64.88 - $75.68 $116,070 - $135,391	-1,789 Reduced 27.42%	4,736 $342,000
Q1 2018 Apr 12, 2018	SELL	$72.84 - $88.8 $15,077 - $18,381	-207 Reduced 3.07%	6,525 $491,000
Q4 2017 Jan 24, 2018	BUY	$71.15 - $83.52 $40,840 - $47,940	574 Added 9.32%	6,732 $496,000
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $444,053 - $526,324	6,158	6,158 $506,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Gilead Sciences, Inc. Transaction History